General MedicationsOPHTHALMICStandard
ZOLYMBUS
BIMATOPROST
Standard Dose
0.01%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ZOLYMBUS is listed in Drugs@FDA under application 217307 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BIMATOPROST Form and strength GEL;OPHTHALMIC - 0.01% Sponsor THEA PHARMA Submission history Latest submission status date: 2025-09-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZOLYMBUS is listed in Drugs@FDA under application 217307 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BIMATOPROST Form and strength GEL;OPHTHALMIC - 0.01% Sponsor THEA PHARMA Submission history Latest submission status date: 2025-09-09 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.